Description
+ Include: 19 videos + 1 pdf, size: 2.23 GB
+ Information:
Conference Overview
The Scripps Cardiomyopathy and Cardio-Oncology Symposium is designed to provide a state-of-the-art, comprehensive curriculum that addresses important clinical topics relevant to cardiomyopathy and the cardiovascular health of cancer patients and survivors. Cardio-oncology is an important and emerging field of medicine resulting from new or unexpected cardiovascular toxicities many cancer survivors are now experiencing because of their cancer treatments. In addition, cardiac amyloidosis is a burgeoning disease with exciting new treatments. Nationally recognized faculty in the fields of cardiology and oncology will discuss challenging topics related to common cardiomyopathies as well as current best practices for diagnosing, treating and managing patients. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient care.
Educational Objectives
After attending this live activity, participants should be able to:
• Evaluate current and emerging treatment options for cardiac amyloidosis.
• Discuss diagnosis and treatment considerations for patients with cardiac sarcoidosis.
• Assess the importance of genetic testing and treatment for genetic cardiomyopathies including hypertrophic cardiomyopathy.
• Analyze best practices in the multidisciplinary monitoring and management of cardiac toxicity in patients undergoing cancer therapy.
• Employ management strategies for venous thromboembolism and other cardiovascular complications that may occur in patients with cancer.
• Demonstrate the importance of ongoing cardiac disease monitoring in cancer survivors.
Target Audience
• Cardiologists
• Oncologists
• Internists
• RN, NP, PA
• Sonographers
+ Topics:
brochure_cmp23.pdf
SESSION I CARDIOMYOPATHIES AL Amyloidosis Making the Diagnosis.mp4
SESSION I CARDIOMYOPATHIES Cardiac Sarcoidosis Making the Diagnosis.mp4
SESSION I CARDIOMYOPATHIES Cardiac Sarcoidosis Therapeutic Principles.mp4
SESSION I CARDIOMYOPATHIES Current and Emerging Treatments for AL Amyloidosis.mp4
SESSION I CARDIOMYOPATHIES Current Treatments for ATTR.mp4
SESSION I CARDIOMYOPATHIES Emerging Therapies for ATTR.mp4
SESSION I CARDIOMYOPATHIES Genetic Cardiomyopathies Who to Screen and What to Look For.mp4
SESSION I CARDIOMYOPATHIES How To Make the Diagnosis of ATTR.mp4
SESSION I CARDIOMYOPATHIES Hypertrophic Cardiomyopathy Diagnosis and Treatment.mp4
SESSION I CARDIOMYOPATHIES Panel Discussion Q&A.mp4
SESSION I CARDIOMYOPATHIES Transthyretin Amyloidosis (ATTR) Who to Suspect.mp4
SESSION II CARDIO-ONCOLOGY Best Practices in Surveillance and Management of Cardiac Toxicity in the Cancer Patient The Cardiologist’s Perspective.mp4
SESSION II CARDIO-ONCOLOGY Best Practices in Surveillance and Management of Cardiac Toxicity in the Cancer Patient The Oncologist’s Perspective.mp4
SESSION II CARDIO-ONCOLOGY Cardiac Disease Monitoring in Cancer Survivors.mp4
SESSION II CARDIO-ONCOLOGY Incorporating Multi-Modality Imaging in Cardio-Oncology.mp4
SESSION II CARDIO-ONCOLOGY Management of End-Stage Heart Failure in the Cancer Survivor.mp4
SESSION II CARDIO-ONCOLOGY Management of VTE in the Cancer Patient.mp4
SESSION II CARDIO-ONCOLOGY Panel Discussion Q&A.mp4
SESSION II CARDIO-ONCOLOGY Strategies to Minimize Radiation-Induced Heart Disease.mp4
